tiprankstipranks
Trending News
More News >
Lonza Group Ltd (CH:LONN)
:LONN
Switzerland Market

Lonza Group Ltd (LONN) Earnings Dates, Call Summary & Reports

Compare
18 Followers

Earnings Data

Report Date
Jul 29, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
8.07
Last Year’s EPS
7.51
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Jan 28, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a predominantly positive operational and financial picture: robust revenue growth (+21.7% CC), meaningful margin expansion (CORE EBITDA 31.6%, +1.4pp), strong cash generation (CHF 545m FCF), successful Vacaville integration, and clear 2026 guidance (11%–12% CC sales growth; CORE EBITDA >32%). Challenges were noted—operational issues in Cell & Gene and a small decline in Specialized Modalities, some platform mix dilution in Integrated Biologics, FX headwinds (~2.5pp), and continued high multi-year CapEx needs—but these were framed as manageable with remediation plans, maturation of projects, and disciplined capital allocation. Overall, the positive achievements and forward guidance substantially outweigh the contained challenges.
Company Guidance
Lonza guided to 2026 constant‑currency sales growth of 11–12% with CORE EBITDA margin expanding to well above 32% (entering the 32–34% mid‑term corridor earlier than originally planned); CapEx is expected in the high‑teens % of sales for 2026 (normalizing to mid‑to‑high‑teens over the mid‑term). Management flagged an FX headwind of roughly 2% based on mid‑January rates (about 2.5% after recent moves), reiterated continued strong demand and regionalization, and pointed to cash progress (continuing‑business free cash flow CHF 545m in 2025) plus a sizeable pipeline (23 growth CapEx projects totaling CHF 7bn and >CHF 10bn of contracts signed in 2025); Vacaville contributed ~CHF 0.6bn in 2025 and is expected to sustain current revenue levels through 2028 while ramping to full potential in the early 2030s.
Strong Revenue Growth
Continuing Lonza CDMO business delivered CHF 6.5 billion in sales for FY2025, an increase of CHF 1.0 billion versus FY2024 and +21.7% in constant currencies, ahead of upgraded guidance (20%–21%).
Margin Expansion and Profitability
CORE EBITDA margin expanded to 31.6%, up 1.4 percentage points versus prior year and above the guided range of 30%–31%; management expects further expansion to above 32% in 2026.
Vacaville Integration and Contribution
Vacaville acquisition (paid CHF 1.1 billion) contributed roughly CHF 0.6 billion in sales in 2025 (slightly above prior CHF 0.5 billion forecast), successful tech transfer, post-merger integration finalized mid-2025, and only minor FDA observations resolved rapidly.
Organic Growth in Underlying Business
Excluding Vacaville, the organic CDMO business grew at low-teens in line with Lonza's CDMO organic growth model; management cites underlying market/outlook supporting low-teens structural growth (10%–13%).
Contracting Momentum and Future Revenue Visibility
Commercial contracting well above CHF 10 billion signed in 2025 (adds to CHF10bn+ in prior years) providing multi-year revenue visibility; 23 large growth CapEx projects (~CHF 7 billion) underway, 90% aimed at commercial/mixed assets in U.S. and Europe.
Platform Outperformance – Advanced Synthesis (ADS)
ADS grew ~22% organically in 2025 with margin improvement of ~5 percentage points to ~42%, driven by bioconjugates and small molecule ramp-ups; management expects ADS margins to remain a strong contributor going forward.
Cash Generation and Working Capital Improvement
Continuing business free cash flow of CHF 545 million in 2025 (almost double 2024), driven by disciplined CapEx, strong inventory and trade working capital management (trade working capital fell as % of sales by ~5 points).
Shareholder Returns and ESG Milestones
Board proposed a 25% dividend increase to CHF 5.00 per share; ESG targets (GHG emission intensity and waste intensity) met five years ahead of schedule with electricity in U.S./Europe/China from renewable sources as of Jan 2026; EcoVadis Gold rating and Ethisphere recognition.

Lonza Group Ltd (CH:LONN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:LONN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 29, 2026
2026 (Q2)
8.07 / -
7.51
Jan 28, 2026
2025 (Q4)
9.50 / 8.62
7.997.88% (+0.63)
Jul 23, 2025
2025 (Q2)
7.06 / 7.51
7.026.98% (+0.49)
Jan 29, 2025
2024 (Q4)
7.99 / 7.99
6.2727.43% (+1.72)
Jul 25, 2024
2024 (Q2)
5.08 / 7.02
6.1214.71% (+0.90)
Jan 26, 2024
2023 (Q4)
6.85 / 6.27
7.43-15.61% (-1.16)
Jul 21, 2023
2023 (Q2)
8.32 / 6.12
7.28-15.93% (-1.16)
Jan 25, 2023
2022 (Q4)
7.10 / 7.43
5.6731.04% (+1.76)
Jul 22, 2022
2022 (Q2)
7.30 / 7.28
6.974.45% (+0.31)
Jan 26, 2022
2021 (Q4)
6.18 / 5.67
6.48-12.50% (-0.81)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CH:LONN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jan 28, 2026
CHF558.40CHF546.80-2.08%
Jul 23, 2025
CHF555.00CHF570.60+2.81%
Jan 29, 2025
CHF590.47CHF574.98-2.62%
Jul 25, 2024
CHF518.97CHF555.91+7.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Lonza Group Ltd (CH:LONN) report earnings?
Lonza Group Ltd (CH:LONN) is schdueled to report earning on Jul 29, 2026, TBA (Confirmed).
    What is Lonza Group Ltd (CH:LONN) earnings time?
    Lonza Group Ltd (CH:LONN) earnings time is at Jul 29, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Lonza Group Ltd stock?
          The P/E ratio of Lonza Group Ltd is N/A.
            What is CH:LONN EPS forecast?
            CH:LONN EPS forecast for the fiscal quarter 2026 (Q2) is 8.07.